Harley-Davidson Inc vs Novavax Inc — how do they compare? Harley-Davidson Inc trades at $26.91 (market cap $2.78B), while Novavax Inc trades at $7.95 (market cap $1.31B). The key difference: Harley-Davidson Inc is far larger — about 2.1× Novavax Inc's market cap, and Harley-Davidson Inc pays a 2.75% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| HOG | NVAX | |
|---|---|---|
Market Cap | $2.78B | $1.31B |
Sector | Consumer Cyclical | Health |
52-Week High | $31.03 | $11.19 |
52-Week Low | $17.19 | $6.22 |
Enterprise Value | $3.19B | $889.30M |
Dividend Yield | 2.75% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novavax (NVAX) trades at $7.89, down 0.75% on the day, with a bullish technical signal despite mixed indicators. The company reported a strong Q2 2026 earnings beat, raising its full-year revenue outlook, while maintaining a low valuation with a P/E of 3.14 and EV/EBITDA of 1.72. However, negative net income margin and shareholder equity highlight financial challenges.
The outlook is cautiously optimistic, driven by partnership milestones with Sanofi and cost reductions, but risks include persistent cash burn and competitive vaccine market pressures. Analyst consensus leans bullish with 74% buy ratings, suggesting potential upside if execution improves.
Trailing returns across standard periods
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →